Allianz Asset Management GmbH increased its holdings in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 9.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 167,835 shares of the semiconductor company's stock after purchasing an additional 14,077 shares during the period. Allianz Asset Management GmbH owned approximately 0.52% of Silicon Laboratories worth $24,732,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Quarry LP acquired a new stake in Silicon Laboratories during the first quarter valued at $25,000. Skandinaviska Enskilda Banken AB publ acquired a new stake in Silicon Laboratories during the first quarter valued at $34,000. Larson Financial Group LLC acquired a new stake in Silicon Laboratories during the first quarter valued at $55,000. Jones Financial Companies Lllp grew its position in Silicon Laboratories by 121.4% during the first quarter. Jones Financial Companies Lllp now owns 496 shares of the semiconductor company's stock valued at $56,000 after buying an additional 272 shares during the period. Finally, Advisors Asset Management Inc. grew its position in Silicon Laboratories by 38.4% during the first quarter. Advisors Asset Management Inc. now owns 631 shares of the semiconductor company's stock valued at $71,000 after buying an additional 175 shares during the period.
Silicon Laboratories Stock Down 1.2%
Shares of NASDAQ SLAB opened at $136.11 on Monday. The company's 50-day simple moving average is $134.01 and its 200-day simple moving average is $127.78. Silicon Laboratories, Inc. has a 52-week low of $82.82 and a 52-week high of $160.00. The firm has a market cap of $4.47 billion, a price-to-earnings ratio of -42.27 and a beta of 1.51.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.02. The firm had revenue of $192.85 million for the quarter, compared to the consensus estimate of $192.57 million. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The company's revenue for the quarter was up 32.6% on a year-over-year basis. During the same period last year, the firm posted ($0.56) earnings per share. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. Equities research analysts anticipate that Silicon Laboratories, Inc. will post -0.97 EPS for the current fiscal year.
Analyst Ratings Changes
Several analysts recently commented on the stock. Morgan Stanley dropped their price target on shares of Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 6th. Stifel Nicolaus raised their price target on shares of Silicon Laboratories from $144.00 to $160.00 and gave the company a "buy" rating in a research report on Friday, July 18th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Silicon Laboratories in a research report on Wednesday, October 8th. Susquehanna lifted their target price on shares of Silicon Laboratories from $110.00 to $150.00 and gave the company a "neutral" rating in a research report on Tuesday, July 22nd. Finally, KeyCorp lifted their target price on shares of Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a research report on Tuesday, July 8th. Five analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $151.13.
Read Our Latest Stock Report on SLAB
Insider Buying and Selling at Silicon Laboratories
In other news, SVP Brandon Tolany sold 8,000 shares of the firm's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $145.23, for a total value of $1,161,840.00. Following the transaction, the senior vice president directly owned 62,328 shares of the company's stock, valued at approximately $9,051,895.44. This trade represents a 11.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders have sold 12,070 shares of company stock valued at $1,703,472 over the last quarter. Company insiders own 1.60% of the company's stock.
Silicon Laboratories Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.